Non-Small Cell Lung Cancer
Showing 9976 - 10000 of >10,000
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)
Active, not recruiting
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Carboplatin
- +4 more
-
Duarte, California
- +3 more
Oct 24, 2022
Cardiovascular Disease, Cancer Trial in Boston, Seattle (Cocoa extract, Multivitamin, Cocoa extract )
Active, not recruiting
- Cardiovascular Disease
- Cancer
- Cocoa extract
- +3 more
-
Boston, Massachusetts
- +1 more
Jul 11, 2022
Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization, Tyrosine Kinase Inhibitor Trial in Chengdu (lenvatinib
Enrolling by invitation
- Hepatocellular Carcinoma Non-resectable
- +3 more
- lenvatinib + sindilimab/carrelizumab
- TACE
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
May 23, 2022
Insomnia Trial in Philadelphia (Assisted Relaxation Therapy, Modified Assisted Relaxation Therapy)
Not yet recruiting
- Insomnia
- Assisted Relaxation Therapy
- Modified Assisted Relaxation Therapy
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 2, 2022
Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best
Not yet recruiting
- Muscle Invasive Bladder Carcinoma
- +2 more
- Best Practice
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 18, 2023
Hereditary Diseases Trial in Aalborg (Whole genome amplification)
Recruiting
- Hereditary Diseases
- Whole genome amplification
-
Aalborg, DenmarkFertility Unit, Aalborg University Hospital
Jul 7, 2022
Pathological Manifestation in Thyroid Follicular Neoplasm: Early
Not yet recruiting
- Thyroid Cancer
- Follicular Thyroid Cancer
- (no location specified)
Jul 20, 2022
Serplulimab in 2L and Above Treatment of Cervical Cancer
Recruiting
- Cervical Cancer
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
May 30, 2023
Endothelial Changes in Pseudoexfoliation Syndrome
Not yet recruiting
- Endothelial Cell Loss, Corneal
- Specular Microscopy
- (no location specified)
Jan 15, 2022
CNS Tumor, Infantile Fibrosarcoma, Recurrent Acute Leukemia Trial in Canada, United States (Larotrectinib Sulfate)
Active, not recruiting
- Central Nervous System Neoplasm
- +4 more
- Larotrectinib Sulfate
-
Birmingham, Alabama
- +81 more
Jan 24, 2023
SCD Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Isoquercetin, Placebo)
Recruiting
- VTE
- Isoquercetin
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Lung Near-Infrared Spectroscopy (NIRS) in Preterm Infants
Not yet recruiting
- Respiratory Distress Syndrome, Newborn
- Neer Infrared Spectroscopy
-
Los Angeles, CaliforniaLos Angeles General Medical Center
Jul 18, 2023
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Skejby, Odense, Copenhagen (Thioguanine (oral))
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Thioguanine (oral)
-
Skejby, Aarhus, Denmark
- +3 more
Apr 14, 2020
Scleroderma, Cardiac Involvement, Autologous Stem Cell Transplantation Trial in Tuebingen (Autologous stemcell transplantation
Active, not recruiting
- Scleroderma
- +2 more
- Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
-
Tuebingen, GermanyUniversity Hospital Tuebingen; Department of oncology, hematolog
May 16, 2022
Hypercholesterolemia Trial in Adelaide (Swisse Nutra+ Cholesterol Balance, Placebo)
Completed
- Hypercholesterolemia
- Swisse Nutra+ Cholesterol Balance
- Placebo
-
Adelaide, South Australia, AustraliaCSIRO Nutrition and Health Research Clinic
Mar 9, 2022
Anti-Cancer Treatment and Clinical Outcome in Newly Diagnosed
Active, not recruiting
- Breast Cancer
- Bevacizumab
- +5 more
-
Buenos Aires, Argentina
- +30 more
Aug 2, 2022
COPD Trial in Chengdu (TLD, Sham TLD procedure, Standard of care)
Not yet recruiting
- COPD
- TLD
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Apr 3, 2023
Compensation to Maintain Cognitive Function in Adults Newly
Completed
- Primary Brain Tumor
- Brain Metastases, Adult
- Neuropsychological Testing
-
Durham, North CarolinaDuke University Medical Center
Jan 19, 2023
Postoperative Complications, Thoracic Surgery Trial in Poznan (Postoperative systematic bronchial aspiration.)
Recruiting
- Postoperative Complications
- Thoracic Surgery
- Postoperative systematic bronchial aspiration.
-
Poznań, Wielkopolska, PolandWielkopolskie Centrum Pulmonologii i Torakochirurgii
Jul 11, 2022
Diffuse Large B-cell Lymphoma, High-Grade B-cell Lymphoma Trial in Worldwide (RO6870810, Venetoclax, Rituximab)
Completed
- Diffuse Large B-cell Lymphoma
- High-Grade B-cell Lymphoma
- RO6870810
- +2 more
-
Duarte, California
- +8 more
Jan 21, 2022
Sickle Cell Disease Trial in United States (Provider-level intervention, Patient-level intervention)
Active, not recruiting
- Sickle Cell Disease
- Provider-level intervention
- Patient-level intervention
-
Little Rock, Arkansas
- +14 more
Feb 24, 2022
Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,
Recruiting
- Recurrent Neuroblastoma
- +3 more
- Cyclophosphamide
- +2 more
-
Palo Alto, California
- +3 more
Jan 25, 2023
Colorectal Adenomatous Polyp, Colorectal Carcinoma, Familial Adenomatous Polyposis Trial in United States (procedure, drug,
Not yet recruiting
- Colorectal Adenomatous Polyp
- +3 more
- Biopsy
- +5 more
-
Ann Arbor, Michigan
- +4 more
Jan 3, 2023
Advanced Solid Tumors, Colorectal Cancer, Squamous Cell Head Neck Cancer Trial in United States (MM-151, MM-151 + irinotecan)
Completed
- Advanced Solid Tumors
- +4 more
- MM-151
- MM-151 + irinotecan
-
Aurora, Colorado
- +3 more
Mar 20, 2018
Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)
Recruiting
- Acute Myeloid Leukemia
- Decitabine and Cedazuridine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022